The KOSDAQ Market Division of the Korea Exchange announced on July 20 that a rights offering-related ex-rights date for NGeneBio will occur on July 21. The reference price is set at 1,404 won.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing